Advances in genitourinary cancer treatment after the 2025 European Society of Medical Oncology congress
Several new clinical trial results were presented at the 2025 European Society for Medical Oncology Congress in Berlin, some of which may change the therapeutic landscape for bladder, prostate, and kidney cancers. In this review, the most important urooncological studies are highlighted, with a focus on those featured during the Congress Presidential Session.
Authors
- Dawid Sigorski (ORCID: https://orcid.org/0000-0002-4799-9611)
- Małgorzata Osmola (ORCID: https://orcid.org/0000-0001-6188-7328)
- MIchal Wilk
- Błażej Urbanowicz
Institutions
- University of Warmia and Mazury in Olsztyn (PL)
Publication Details
- Journal
- Oncology in Clinical Practice
- Published
- 2025-12-23
- DOI
- https://doi.org/10.5603/ocp.109830
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00